Esomeprazole MAG DR 40 MG cap 30S
Ended Awarded
- Contract number
- SPE2DB25FRQY4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,711
Award facts
- Contract value 100% obligated
- $2,710.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,710.84 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and runs through December 2026.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Esomeprazole, a common gastrointestinal medication, exemplifies the routine pharmaceutical supply requirements fulfilled through this expansive contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FRQY4?
SPE2DB25FRQY4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FRQY4 worth?
The government has obligated $2,711 on SPE2DB25FRQY4.
Is contract SPE2DB25FRQY4 an order under another contract?
Yes. SPE2DB25FRQY4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRQY4 competed?
The extent of competition for SPE2DB25FRQY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award